IMA Group Expands with New York Acquisition of Medical Research Network

Deal News | Jul 21, 2025 | Centre Partners Management LLC

The IMA Group, a leading provider in medical and behavioral health services, has announced its acquisition of the Medical Research Network (MRN) LLC, a clinical research site based in New York City focusing on central nervous system (CNS) disorders, particularly in psychiatry and neurology. This acquisition aims to enhance IMA's presence in high-need therapeutic areas, especially in mental health, and improve access to clinical trials for diverse and underserved populations. Dr. Michael R. Liebowitz, a key figure in psychiatry with extensive contributions to the research of anxiety and mood disorders, will continue to lead MRN. By integrating MRN into its national framework, IMA seeks to bolster its capacity to conduct efficient and high-quality CNS trials, further building on its existing research footprint across various U.S. cities. With a strategic aim for growth through acquisitions, IMA's consolidation of MRN signifies its dedication to becoming a major player in outsourced healthcare evaluation and clinical research services across the nation.

Sectors

  • Healthcare Services
  • Clinical Research
  • Venture Capital & Private Equity

Geography

  • United States – The IMA Group, along with MRN, operates within the United States, making it the primary geographic focus of the article.
  • New York – The acquisition takes place in New York, with MRN being a New York City-based clinical research site.

Industry

  • Healthcare Services – This sector involves companies that provide medical and health-related services, which is relevant as The IMA Group provides medical and behavioral health services.
  • Clinical Research – Involves organizations that conduct clinical trials and medical studies. The acquisition focuses on enhancing The IMA Group's clinical research capabilities, particularly in CNS disorders.
  • Venture Capital & Private Equity – Centre Partners Management LLC, a private equity firm, backs The IMA Group, illustrating a connection to investment sectors.

Financials

  • – The financial terms of the acquisition were not disclosed.

Participants

NameRoleTypeDescription
The IMA GroupAcquirerCompanyA provider of medical and behavioral health services, involved in clinical research and health evaluations across the U.S.
Medical Research Network (MRN) LLCTargetCompanyA clinical research site in New York City specializing in psychiatry and neurology trials focused on CNS disorders.
Centre Partners Management LLCPrivate Equity FirmCompanyA private equity firm backing The IMA Group, involved in facilitating the acquisition.
Michael R. Liebowitz, MDCEO and Principal InvestigatorPersonFounder of MRN, Board Certified in Psychiatry with a prominent role in research related to anxiety and mood disorders.
Mark Weinberger, PhD, MPHPresident and CEO of The IMA GroupPersonLeader of The IMA Group, emphasizes the strategic benefit of the acquisition for the company.